Hisamitsu Pharmaceutical: brands it owns and its ownership tree
Hisamitsu Pharmaceutical (TSE: 4530) is a publicly listed company headquartered in Japan that owns 3 consumer brands.[1]
Hisamitsu Pharmaceutical is a Japanese drug maker, listed in Tokyo, built around transdermal patches. Its integrated report gives the founding year as 1847, with head offices in Kyushu (main) and Tokyo, and traces its patch business to Asahi Mankinko in 1907. It also sells prescription patches through Noven Pharmaceuticals in the United States. Only its over-the-counter pain-relief brands are recorded here.
-
brands owned
-
1
categories
-
0
acquisitions recorded
-
0
divestitures recorded
Company facts
- Legal name
- Hisamitsu Pharmaceutical Co., Inc.
- Type
- publicly listed company · see all publicly listed company owners
- Headquarters
- 🇯🇵 Japan
- Founded
- 1847
- Tickers
- TSE: 4530
- Website
- global.hisamitsu
- Last verified
- · 1 sources
Hisamitsu Pharmaceutical in numbers
- Hisamitsu Pharmaceutical owns 3 consumer brands tracked here across 1 top-level categories; the largest is consumer health with 3 brands.[1]
Everything Hisamitsu Pharmaceutical owns
Controlling ownership as of . Brands grouped under the entity that owns them; large groups are collapsed.
Full-screen interactive tree →
Brand portfolio by category
Recent changes to this record
Frequently asked questions
What brands does Hisamitsu Pharmaceutical own?
Hisamitsu Pharmaceutical owns 3 consumer brands tracked here, including Salonpas, Air Salonpas and Feitas.
Is Hisamitsu Pharmaceutical a Japanese company?
Yes. Hisamitsu Pharmaceutical is headquartered in Japan and was founded in 1847.
Who owns Hisamitsu Pharmaceutical?
Hisamitsu Pharmaceutical is a publicly listed company owned by its shareholders; it trades as 4530 on the TSE.
Sources (1) & corrections
Last verified . Every ownership fact above is backed by one of these primary documents. Numbers in brackets in the text refer to this list.
- [1] Hisamitsu Pharmaceutical Group Integrated Report 2025 — Hisamitsu Pharmaceutical Co., Inc., Annual report; retrieved 3 October 2026.
Report a correction Opens a pre-filled GitHub issue. See our corrections policy.